Ledger.Open graph →
SEC Form D · filed September 9, 2021

Ankyra Therapeutics, Inc

Offering
$45.0M
Sold
$45.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
BOSTON, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (10)

Tillman Gerngross · Boston, MAExec · DirectorTerrance Mcguire · Boston, MADirectorGary H. Grossman · Pismo Beach, CADirectorBrendan T. Synnott · Avon, COExec · DirectorAjay Royan · Woburn, MADirectorPhilip Ferneau · Portland, MEDirectorKurt Polk · GREENWICH, CTDirectorAxiom Investors LLC · Greenwich, CTExec · DirectorAjay Royan · San Francisco, CADirectorPhilip Ferneau · Portland, MEDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗